Fundraising FoxBioTime, Inc.
Alameda, US
Find your way into BioTime, Inc.
Sign up to see every warm intro you have to BioTime, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BioTime, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Benchlight Science is a publication that explains the vocabulary and concepts used in biotechnology and life-science research. It targets students, curious readers, and non-specialists with plain-English definitions of terms, measurements, and research methods.
Founders & leadership
JS
Judith SegallFounder
RW
Robert W PeabodyExecutive
MD
Michael D WestExecutive
WP
William P. TewExecutive
Board
NC
Neal C BradsherBoard director
AD
Alfred D KingsleyBoard director
FM
Franklin M. BergerBoard director
SF
Stephen FarrellBoard director
HL
Henry L. NordhoffBoard director
AC
Andrew C. von EschenbachBoard director
PL
Pedro LichtingerBoard director
Reported raises · per SEC filings
Form D private placements$3.5M disclosed across 1 round · 2014
▶$3.5MraisedMar 2014 · 3 investors · BiotechnologyRule 506(b)
▶$3.5MraisedMar 2014 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Judith SegallDirector
- Franklin M. BergerDirector
- Neal C BradsherDirector
- Robert W PeabodyExecutive Officer
- Michael D WestExecutive Officer, Director
- Stephen FarrellDirector
- Henry L. NordhoffDirector
- William P. TewExecutive Officer
- Andrew C. von EschenbachDirector
- Pedro LichtingerDirector
- Alfred D KingsleyDirector
- Offering amount
- $15M
- Amount sold
- $3.5M
- Minimum investment
- $500K
- First sale
- Mar 2014
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 7 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2018 | $385.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $2.2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $224.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $285.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $335.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2004 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2004 | $300K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does BioTime, Inc. do?
- Benchlight Science is a publication that explains the vocabulary and concepts used in biotechnology and life-science research. It targets students, curious readers, and non-specialists with plain-English definitions of terms, measurements, and research methods.
- Who founded BioTime, Inc.?
- BioTime, Inc. was founded by Judith Segall.
- How much funding has BioTime, Inc. raised?
- BioTime, Inc. has disclosed $3.5M raised across 1 round.
- Where is BioTime, Inc. headquartered?
- BioTime, Inc. is headquartered in Alameda, US.